Biotech | November 08, 2021
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Biocon Biologics and Viatris co-developed the products
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
Sun Pharma has reported consolidated financial results for the period ended September 30, 2021.
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech
Subscribe To Our Newsletter & Stay Updated
